<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502487</url>
  </required_header>
  <id_info>
    <org_study_id>WestChinaHAesthesia-1</org_study_id>
    <nct_id>NCT02502487</nct_id>
  </id_info>
  <brief_title>Dorsal Penile Nerve Block for Rigid Cystoscopy in Men</brief_title>
  <official_title>Dorsal Penile Nerve Block for Rigid Cystoscopy in Men: a Single-center, Randomized, Double-blind and Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the effectiveness and safety of dorsal penile nerve block (DPNB) in
      men undergoing rigid cystoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain is common in men undergoing rigid cystoscopy. Even with application of a lubricant
      containing 2% lidocaine, about 76% men suffer from mild to severe pain when undergoing rigid
      cystoscopy, and approximately 27% men could still feel mild to moderate pain 7 days after the
      procedure. The most painful part of the procedure for men is when the cystoscope passes
      through the membranous urethra. Song et al did autopsy on males found dorsal nerve of the
      penis (DNP), the terminal branch of the pudendal nerve, innervates the membranous urethra in
      53.3% specimens. In addition, urethral mucosa has branches of DNP innervated. Dorsal penile
      nerve block (DPNB) is usually used for circumcision in children and it has been shown to
      provide effective analgesia for penile surgeries. According to the evidence that some DNP
      branches innervate membranous urethra and urethra mucosa and most pain originates from
      cystoscope passing through membranous urethra, we speculated that DPNB could overall reduce
      pain level in men during rigid cystoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) for Pain</measure>
    <time_frame>at cystoscopic inspection of external sphincter</time_frame>
    <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) for Pain</measure>
    <time_frame>before gel administration</time_frame>
    <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) for Pain</measure>
    <time_frame>at cystoscopic inspection of penile and bulbar urethra</time_frame>
    <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) for Pain</measure>
    <time_frame>at cystoscopic inspection of prostate and bladder</time_frame>
    <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) for Pain</measure>
    <time_frame>after withdrawal of cystoscope</time_frame>
    <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Before Gel Administration</measure>
    <time_frame>before gel administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra</measure>
    <time_frame>at cystoscopic inspection of penile and bulbar urethra</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate at Cystoscopic Inspection of External Sphincter</measure>
    <time_frame>at cystoscopic inspection of external sphincter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate After Withdrawal of Cystoscope</measure>
    <time_frame>after withdrawal of cystoscope</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure Before Gel Administration</measure>
    <time_frame>before gel administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra</measure>
    <time_frame>at cystoscopic inspection of penile and bulbar urthra</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter</measure>
    <time_frame>at cystoscopic inspection of external sphincter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure After Withdrawal of Cystoscope</measure>
    <time_frame>after withdrawal of cystoscope</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation by Pulse Before Gel Administration</measure>
    <time_frame>before gel administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra</measure>
    <time_frame>at cystoscopic inspection of penile and bulbar urthra</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter</measure>
    <time_frame>at cystoscopic inspection of external sphincter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation by Pulse After Withdrawal of Cystoscope</measure>
    <time_frame>after withdrawal of cystoscope</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breath Rate Before Gel Administration</measure>
    <time_frame>before gel administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra</measure>
    <time_frame>at cystoscopic inspection of penile and bulbar Urthra</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breath Rate at Cystoscopic Inspection of External Sphincter</measure>
    <time_frame>at cystoscopic inspection of external sphincter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breath Rate After Withdrawal of Cystoscope</measure>
    <time_frame>after withdrawal of cystoscope</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">258</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Tetracaine gel group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal penile nerve block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dorsal Penile Nerve Block</intervention_name>
    <description>Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis</description>
    <arm_group_label>Dorsal penile nerve block group</arm_group_label>
    <arm_group_label>Combination group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
    <arm_group_label>Dorsal penile nerve block group</arm_group_label>
    <arm_group_label>Combination group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tetracaine</intervention_name>
    <description>1% Tetracaine gel instilled into urethra</description>
    <arm_group_label>Tetracaine gel group</arm_group_label>
    <arm_group_label>Combination group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) Physical Status I-II

          -  Without history of urethral or prostatic surgery

          -  Without respiration or circulation disorders

          -  Without chronic pain

        Exclusion Criteria:

          -  Allergy to local anesthetics

          -  Coagulation disorder or usage of antiplatelet drugs

          -  Infection at the site of puncture point

          -  Severe urethral stenosis
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guizhi Du, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>West China Hospital of Sichuan University, Department of Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University, Department of Anesthesiology</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M; European Association of Urology. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12. Review.</citation>
    <PMID>23827737</PMID>
  </reference>
  <reference>
    <citation>Ramsey EW, Elhilali M, Goldenberg SL, Nickel CJ, Norman R, Perreault JP, Piercy B, Trachtenberg J. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council. J Urol. 2000 Feb;163(2):499-502.</citation>
    <PMID>10647665</PMID>
  </reference>
  <reference>
    <citation>Goldfischer ER, Cromie WJ, Karrison TG, Naszkiewicz L, Gerber GS. Randomized, prospective, double-blind study of the effects on pain perception of lidocaine jelly versus plain lubricant during outpatient rigid cystoscopy. J Urol. 1997 Jan;157(1):90-4.</citation>
    <PMID>8976223</PMID>
  </reference>
  <reference>
    <citation>Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hübner W, Breinl E, Riedl C, Engelhardt PF. Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in men. Urology. 2015 Apr;85(4):737-41. doi: 10.1016/j.urology.2015.01.007.</citation>
    <PMID>25817101</PMID>
  </reference>
  <reference>
    <citation>Taghizadeh AK, El Madani A, Gard PR, Li CY, Thomas PJ, Denyer SP. When does it hurt? Pain during flexible cystoscopy in men. Urol Int. 2006;76(4):301-3.</citation>
    <PMID>16679829</PMID>
  </reference>
  <reference>
    <citation>Song LJ, Lu HK, Wang JP, Xu YM. Cadaveric study of nerves supplying the membranous urethra. Neurourol Urodyn. 2010 Apr;29(4):592-5. doi: 10.1002/nau.20768.</citation>
    <PMID>19760755</PMID>
  </reference>
  <reference>
    <citation>Kozacioglu Z, Kiray A, Ergur I, Zeybek G, Degirmenci T, Gunlusoy B. Anatomy of the dorsal nerve of the penis, clinical implications. Urology. 2014 Jan;83(1):121-4. doi: 10.1016/j.urology.2013.07.075. Epub 2013 Nov 12.</citation>
    <PMID>24238564</PMID>
  </reference>
  <reference>
    <citation>Kirya C, Werthmann MW Jr. Neonatal circumcision and penile dorsal nerve block--a painless procedure. J Pediatr. 1978 Jun;92(6):998-1000.</citation>
    <PMID>660375</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2015</study_first_submitted>
  <study_first_submitted_qc>July 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <results_first_submitted>April 14, 2016</results_first_submitted>
  <results_first_submitted_qc>May 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 11, 2016</results_first_posted>
  <last_update_submitted>July 13, 2016</last_update_submitted>
  <last_update_submitted_qc>July 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Yan Qiu</investigator_full_name>
    <investigator_title>Attending Physician</investigator_title>
  </responsible_party>
  <keyword>Analgesia</keyword>
  <keyword>Cystoscopy</keyword>
  <keyword>Dorsal nerve of penis</keyword>
  <keyword>Nerve block</keyword>
  <keyword>Ropivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Tetracaine Gel Group</title>
          <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
        </group>
        <group group_id="P2">
          <title>Dorsal Penile Nerve Block Group</title>
          <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
        </group>
        <group group_id="P3">
          <title>Combination Group</title>
          <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="86"/>
                <participants group_id="P2" count="86"/>
                <participants group_id="P3" count="86"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="86"/>
                <participants group_id="P2" count="86"/>
                <participants group_id="P3" count="86"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tetracaine Gel Group</title>
          <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
        </group>
        <group group_id="B2">
          <title>Dorsal Penile Nerve Block Group</title>
          <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
        </group>
        <group group_id="B3">
          <title>Combination Group</title>
          <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="86"/>
            <count group_id="B2" value="86"/>
            <count group_id="B3" value="86"/>
            <count group_id="B4" value="258"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.4" spread="11.5"/>
                    <measurement group_id="B2" value="52.1" spread="13.0"/>
                    <measurement group_id="B3" value="53.5" spread="12.0"/>
                    <measurement group_id="B4" value="53.0" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="86"/>
                    <measurement group_id="B4" value="258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body weight</title>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.8" spread="8.2"/>
                    <measurement group_id="B2" value="68.8" spread="9.6"/>
                    <measurement group_id="B3" value="66.4" spread="8.9"/>
                    <measurement group_id="B4" value="67.3" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="167.3" spread="5.6"/>
                    <measurement group_id="B2" value="168.7" spread="5.5"/>
                    <measurement group_id="B3" value="167.8" spread="6.4"/>
                    <measurement group_id="B4" value="167.9" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>Kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.8" spread="2.4"/>
                    <measurement group_id="B2" value="24.2" spread="3.0"/>
                    <measurement group_id="B3" value="23.6" spread="2.7"/>
                    <measurement group_id="B4" value="23.8" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of cystoscopy</title>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.5" spread="0.6"/>
                    <measurement group_id="B2" value="3.5" spread="0.5"/>
                    <measurement group_id="B3" value="3.4" spread="0.5"/>
                    <measurement group_id="B4" value="3.5" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cystoscopy history</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>First-time cystoscopy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Repeat cystoscopy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale (VAS) for Pain</title>
        <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
        <time_frame>at cystoscopic inspection of external sphincter</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) for Pain</title>
          <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="5" upper_limit="7"/>
                    <measurement group_id="O2" value="4" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="O3" value="4" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Scale (VAS) for Pain</title>
        <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
        <time_frame>before gel administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) for Pain</title>
          <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Scale (VAS) for Pain</title>
        <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
        <time_frame>at cystoscopic inspection of penile and bulbar urethra</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) for Pain</title>
          <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O3" value="1" lower_limit="1" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Scale (VAS) for Pain</title>
        <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
        <time_frame>at cystoscopic inspection of prostate and bladder</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) for Pain</title>
          <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Scale (VAS) for Pain</title>
        <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
        <time_frame>after withdrawal of cystoscope</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) for Pain</title>
          <description>A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients’ pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate Before Gel Administration</title>
        <time_frame>before gel administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate Before Gel Administration</title>
          <units>Beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.0" spread="9.7"/>
                    <measurement group_id="O2" value="75.9" spread="9.4"/>
                    <measurement group_id="O3" value="73.6" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
        <time_frame>at cystoscopic inspection of penile and bulbar urethra</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
          <units>Beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.8" spread="11.7"/>
                    <measurement group_id="O2" value="83.8" spread="12.0"/>
                    <measurement group_id="O3" value="81.1" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate at Cystoscopic Inspection of External Sphincter</title>
        <time_frame>at cystoscopic inspection of external sphincter</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate at Cystoscopic Inspection of External Sphincter</title>
          <units>Beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.7" spread="14.1"/>
                    <measurement group_id="O2" value="90.2" spread="14.9"/>
                    <measurement group_id="O3" value="86.2" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate After Withdrawal of Cystoscope</title>
        <time_frame>after withdrawal of cystoscope</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate After Withdrawal of Cystoscope</title>
          <units>Beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.7" spread="10.9"/>
                    <measurement group_id="O2" value="72.3" spread="10.0"/>
                    <measurement group_id="O3" value="71.6" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Pressure Before Gel Administration</title>
        <time_frame>before gel administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure Before Gel Administration</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.3" spread="10.2"/>
                    <measurement group_id="O2" value="96.6" spread="9.7"/>
                    <measurement group_id="O3" value="95.1" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
        <time_frame>at cystoscopic inspection of penile and bulbar urthra</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" spread="10.6"/>
                    <measurement group_id="O2" value="99.8" spread="10.1"/>
                    <measurement group_id="O3" value="98.2" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter</title>
        <time_frame>at cystoscopic inspection of external sphincter</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113.7" spread="11.7"/>
                    <measurement group_id="O2" value="105.8" spread="10.5"/>
                    <measurement group_id="O3" value="104.8" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Pressure After Withdrawal of Cystoscope</title>
        <time_frame>after withdrawal of cystoscope</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure After Withdrawal of Cystoscope</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.3" spread="9.8"/>
                    <measurement group_id="O2" value="95.7" spread="8.4"/>
                    <measurement group_id="O3" value="95.2" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Saturation by Pulse Before Gel Administration</title>
        <time_frame>before gel administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Saturation by Pulse Before Gel Administration</title>
          <units>percentage</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="98" upper_limit="99"/>
                    <measurement group_id="O2" value="98" lower_limit="97" upper_limit="99"/>
                    <measurement group_id="O3" value="99" lower_limit="98" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
        <time_frame>at cystoscopic inspection of penile and bulbar urthra</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
          <units>percentage</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="98" upper_limit="99"/>
                    <measurement group_id="O2" value="98" lower_limit="98" upper_limit="99"/>
                    <measurement group_id="O3" value="99" lower_limit="98" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter</title>
        <time_frame>at cystoscopic inspection of external sphincter</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter</title>
          <units>percentage</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="98" upper_limit="99"/>
                    <measurement group_id="O2" value="98" lower_limit="97" upper_limit="99"/>
                    <measurement group_id="O3" value="99" lower_limit="98" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Saturation by Pulse After Withdrawal of Cystoscope</title>
        <time_frame>after withdrawal of cystoscope</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Saturation by Pulse After Withdrawal of Cystoscope</title>
          <units>percentage</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="98" upper_limit="99"/>
                    <measurement group_id="O2" value="98" lower_limit="98" upper_limit="99"/>
                    <measurement group_id="O3" value="99" lower_limit="98" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Breath Rate Before Gel Administration</title>
        <time_frame>before gel administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Breath Rate Before Gel Administration</title>
          <units>times per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.8" spread="1.1"/>
                    <measurement group_id="O2" value="19.6" spread="1.6"/>
                    <measurement group_id="O3" value="19.5" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
        <time_frame>at cystoscopic inspection of penile and bulbar Urthra</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra</title>
          <units>times per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" spread="1.2"/>
                    <measurement group_id="O2" value="19.8" spread="1.5"/>
                    <measurement group_id="O3" value="19.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Breath Rate at Cystoscopic Inspection of External Sphincter</title>
        <time_frame>at cystoscopic inspection of external sphincter</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Breath Rate at Cystoscopic Inspection of External Sphincter</title>
          <units>times per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.1" spread="1.3"/>
                    <measurement group_id="O2" value="19.8" spread="1.7"/>
                    <measurement group_id="O3" value="19.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Breath Rate After Withdrawal of Cystoscope</title>
        <time_frame>after withdrawal of cystoscope</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tetracaine Gel Group</title>
            <description>Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
          <group group_id="O2">
            <title>Dorsal Penile Nerve Block Group</title>
            <description>Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis</description>
          </group>
          <group group_id="O3">
            <title>Combination Group</title>
            <description>Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
Dorsal Penile Nerve Block: Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
Ropivacaine: 0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Tetracaine: 1% Tetracaine gel instilled into urethra</description>
          </group>
        </group_list>
        <measure>
          <title>Breath Rate After Withdrawal of Cystoscope</title>
          <units>times per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="86"/>
                <count group_id="O3" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.7" spread="1.2"/>
                    <measurement group_id="O2" value="19.4" spread="1.5"/>
                    <measurement group_id="O3" value="19.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>from beginning of dorsal penile nerve block to end of cystoscopy</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Tetracaine Group</title>
          <description>tetracaine gel plus DPNB with saline</description>
        </group>
        <group group_id="E2">
          <title>DPNB Group</title>
          <description>DPNB with ropivacaine plus plain lubricant</description>
        </group>
        <group group_id="E3">
          <title>Combination Group</title>
          <description>DPNB with ropivacaine plus tetracaine gel</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The VAS scale was the only main observe index, and patients could have different cognition of pain and this may affect the evaluation of pain. The nerve block was not guided by ultrasound, which may improve the analgesic effect.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Guizhi Du, Associate professor</name_or_title>
      <organization>West China Hospital, Department of Anesthesiology</organization>
      <phone>+86 18980602213</phone>
      <email>du_guizhi@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

